These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 21967896)
1. A mimic of viral double-stranded RNA triggers fulminant type 1 diabetes-like syndrome in regulatory T cell-deficient autoimmune diabetic mouse. Tada A; Shimada A; Yamada T; Oikawa Y; Yamada Y; Okubo Y; Irie J; Bluestone JA; Itoh H J Immunol; 2011 Nov; 187(10):4947-53. PubMed ID: 21967896 [TBL] [Abstract][Full Text] [Related]
2. Possible involvement of autoimmunity in fulminant type 1 diabetes. Oikawa Y; Shimada A Diabetol Int; 2020 Oct; 11(4):329-335. PubMed ID: 33088639 [TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells. Brode S; Raine T; Zaccone P; Cooke A J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572 [TBL] [Abstract][Full Text] [Related]
4. T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function. Esensten JH; Lee MR; Glimcher LH; Bluestone JA J Immunol; 2009 Jul; 183(1):75-82. PubMed ID: 19535634 [TBL] [Abstract][Full Text] [Related]
5. Pathological changes in the pancreas of fulminant type 1 diabetes and slowly progressive insulin-dependent diabetes mellitus (SPIDDM): innate immunity in fulminant type 1 diabetes and SPIDDM. Kobayashi T; Nishida Y; Tanaka S; Aida K Diabetes Metab Res Rev; 2011 Nov; 27(8):965-70. PubMed ID: 22069294 [TBL] [Abstract][Full Text] [Related]
6. Recent findings on fulminant type 1 diabetes. Liu L; Zeng L; Sang D; Lu Z; Shen J Diabetes Metab Res Rev; 2018 Jan; 34(1):. PubMed ID: 28817230 [TBL] [Abstract][Full Text] [Related]
8. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666 [TBL] [Abstract][Full Text] [Related]
9. Impact of T-cell-specific Smad4 deficiency on the development of autoimmune diabetes in NOD mice. Kim D; Lee SM; Jun HS Immunol Cell Biol; 2017 Mar; 95(3):287-296. PubMed ID: 27686408 [TBL] [Abstract][Full Text] [Related]
10. Roles for cathepsins S, L, and B in insulitis and diabetes in the NOD mouse. Hsing LC; Kirk EA; McMillen TS; Hsiao SH; Caldwell M; Houston B; Rudensky AY; LeBoeuf RC J Autoimmun; 2010 Mar; 34(2):96-104. PubMed ID: 19664906 [TBL] [Abstract][Full Text] [Related]
11. Transient depletion of CD4+ CD25+ regulatory T cells results in multiple autoimmune diseases in wild-type and B-cell-deficient NOD mice. Ellis JS; Wan X; Braley-Mullen H Immunology; 2013 Jun; 139(2):179-86. PubMed ID: 23293979 [TBL] [Abstract][Full Text] [Related]
12. A selective CD28 antagonist and rapamycin synergise to protect against spontaneous autoimmune diabetes in NOD mice. Besançon A; Goncalves T; Valette F; Mary C; Vanhove B; Chatenoud L; You S Diabetologia; 2018 Aug; 61(8):1811-1816. PubMed ID: 29845333 [TBL] [Abstract][Full Text] [Related]
13. Alternative splice forms of CTLA-4 induced by antisense mediated splice-switching influences autoimmune diabetes susceptibility in NOD mice. Mourich DV; Oda SK; Schnell FJ; Crumley SL; Hauck LL; Moentenich CA; Marshall NB; Hinrichs DJ; Iversen PL Nucleic Acid Ther; 2014 Apr; 24(2):114-26. PubMed ID: 24494586 [TBL] [Abstract][Full Text] [Related]
14. The dual role of scavenger receptor class A in development of diabetes in autoimmune NOD mice. Shimizu M; Yasuda H; Hara K; Takahashi K; Nagata M; Yokono K PLoS One; 2014; 9(10):e109531. PubMed ID: 25343451 [TBL] [Abstract][Full Text] [Related]
15. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis. Hussain S; Delovitch TL J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886 [TBL] [Abstract][Full Text] [Related]
17. The effect of innate immunity on autoimmune diabetes and the expression of Toll-like receptors on pancreatic islets. Wen L; Peng J; Li Z; Wong FS J Immunol; 2004 Mar; 172(5):3173-80. PubMed ID: 14978124 [TBL] [Abstract][Full Text] [Related]
18. RNase L contributes to experimentally induced type 1 diabetes onset in mice. Zeng C; Yi X; Zipris D; Liu H; Zhang L; Zheng Q; Malathi K; Jin G; Zhou A J Endocrinol; 2014 Dec; 223(3):277-87. PubMed ID: 25287058 [TBL] [Abstract][Full Text] [Related]
19. Abrogation of ICOS/ICOS ligand costimulation in NOD mice results in autoimmune deviation toward the neuromuscular system. Prevot N; Briet C; Lassmann H; Tardivel I; Roy E; Morin J; Mak TW; Tafuri A; Boitard C Eur J Immunol; 2010 Aug; 40(8):2267-76. PubMed ID: 20544729 [TBL] [Abstract][Full Text] [Related]
20. Deficiency of Nuclear Factor-κB c-Rel Accelerates the Development of Autoimmune Diabetes in NOD Mice. Ramakrishnan P; Yui MA; Tomalka JA; Majumdar D; Parameswaran R; Baltimore D Diabetes; 2016 Aug; 65(8):2367-79. PubMed ID: 27217485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]